 |
|
Evidence-Based Medicine on Trial
|
|
| Since this article does not have an abstract, we have provided the first 83 words of the full text and any section headings. |
|
|
|
To the Editor: Most often, emotional havoc overshadows financial considerations for physician defendants in medical liability litigation, as so vividly described by Dr Merenstein.1 Such experiences will drive physicians away from practice and dissuade the young and the brightest from studying medicine. While EBM may predict outcomes, delayed diagnosis of cancer remains a most common cause for medical liability action.
Biology is not always predictable. I encourage Merenstein to continue practice, as the emotional satisfaction far outweighs the displeasure of today's litigious climate.
Leonard J. Morse, MD
lmorsemd{at}massmed.org
University of Massachusetts Medical School
Worcester
1. Merenstein D. Winners and losers. JAMA. 2004;291:15-16.
FREE FULL TEXT
Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.
JAMA. 2004;291:1697.
RELATED ARTICLES
Evidence-Based Medicine on Trial
Daphne P. Bicket
JAMA. 2004;291(14):1696.
EXTRACT
| FULL TEXT
Evidence-Based Medicine on Trial
Richard A. Hogan
JAMA. 2004;291(14):1696-1697.
EXTRACT
| FULL TEXT
Evidence-Based Medicine on Trial
Clark Watts
JAMA. 2004;291(14):1697.
EXTRACT
| FULL TEXT
Evidence-Based Medicine on Trial
Mark A. Hall, Michael D. Green, and Arthur Hartz
JAMA. 2004;291(14):1697.
EXTRACT
| FULL TEXT
Evidence-Based Medicine on Trial
Michael Fleming
JAMA. 2004;291(14):1697-1698.
EXTRACT
| FULL TEXT
Evidence-Based Medicine on Trial—Reply
Daniel Merenstein
JAMA. 2004;291(14):1698.
EXTRACT
| FULL TEXT
Winners and Losers
Daniel Merenstein
JAMA. 2004;291(1):15-16.
EXTRACT
| FULL TEXT
|
